Christina Kay

2021

In 2021, Christina Kay earned a total compensation of $246K as Co, Chief Executive Officer at Integrated Biopharma, a 7% increase compared to previous year.

Compensation breakdown

Option Awards$19,035
Salary$218,337
Other$8,657
Total$246,029

Kay received $218.3K in salary, accounting for 89% of the total pay in 2021.

Kay also received $19K in option awards and $8.7K in other compensation.

Rankings

In 2021, Christina Kay's compensation ranked 11,822nd out of 12,415 executives tracked by ExecPay. In other words, Kay earned more than 4.8% of executives.

ClassificationRankingPercentile
All
11,822
out of 12,415
5th
Division
Manufacturing
5,216
out of 5,505
5th
Major group
Chemicals And Allied Products
2,284
out of 2,375
4th
Industry group
Drugs
2,026
out of 2,096
3rd
Industry
Pharmaceutical Preparations
1,498
out of 1,546
3rd
Source: SEC filing on October 27, 2021.

Kay's colleagues

We found three more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2021.

2021

Dina Masi

Integrated Biopharma

Chief Financial Officer

2021

EGerald Kay

Integrated Biopharma

Chairman

2021

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

News

You may also like